ArticleDiabetes & vascular disease research2017

Aleglitazar, a dual peroxisome proliferator-activated receptor-α and -γ agonist, protects cardiomyocytes against the adverse effects of hyperglycaemia.

Yan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.